With 2.34 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.2 million shares. During the session, the REIT – Healthcare Facilities company that operates in wider Real Estate sector, reached to the highest price of $27.77 whereas the lowest price it dropped to was $26.18. The 52-week range on AHR shows that it touched its highest point at $27.21 and its lowest point at $12.63 during that stretch. It currently has a 1-year price target of $27.62. With its current market cap of 4.16 billion, AHR has annualized dividend of $0.75 while the current yield stands at 2.80%.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AHR was up-trending over the past week, with a rise of 6.56%, but this was up by 7.50% over a month. Three-month performance surged to 43.32% while six-month performance rose 84.19%. A look at the trailing 12-month EPS for AHR yields -0.23 with Next year EPS estimates of 0.22. For the next quarter, that number is 0.02. This implies an EPS growth rate of 101.23% for this year and 1525.04% for next year.
Float and Shares Shorts:
At present, 152.87 million AHR shares are outstanding with a float of 151.50 million shares on hand for trading. On 2024-10-31, short shares totaled 5.74 million, which was 375.0 higher than short shares on 1727654400. In addition to Mr. Danny Prosky as the firm’s President, CEO & Director, Mr. Brian S. Peay serves as its Chief Financial Officer.
Institutional Ownership:
Through their ownership of 0.64776003 of AHR’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, AHR reported revenue of $504581000.0 and operating income of $31684000.0. The EBITDA in the recently reported quarter was $89865000.0 and diluted EPS was $0.01.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AHR since 2 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With AHR analysts setting a high price target of 31.0 and a low target of 22.0, the average target price over the next 12 months is 27.625. Based on these targets, AHR could surge 15.67% to reach the target high and fall by -17.91% to reach the target low. Reaching the average price target will result in a growth of 3.08% from current levels.
Analysts have provided yearly estimates in a range of $0.01384189 being high and $0.01282411 being low. For AHR, this leads to a yearly average estimate of $0.013333. The surprise factor in the prior quarter was $0. Based on analyst estimates, the high estimate for the next quarter is $0.08 and the low estimate is $0.02. The average estimate for the next quarter is thus $0.04.
